ArticleDermatology and therapy2018

A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions.

Maria Pia De Padova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.